CAS 1016900-28-9
:Rizatriptan IMpurity B
Description:
Rizatriptan Impurity B, with the CAS number 1016900-28-9, is a chemical compound associated with the pharmaceutical drug rizatriptan, which is primarily used for the treatment of migraines. As an impurity, it may arise during the synthesis or degradation of the active pharmaceutical ingredient. The characteristics of Rizatriptan Impurity B include its molecular structure, which is related to the parent compound, and it may exhibit similar functional groups, influencing its chemical behavior and interactions. Typically, impurities like this are assessed for their potential impact on the efficacy and safety of the drug formulation. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are commonly employed to identify and quantify such impurities. Understanding the properties of impurities is crucial for regulatory compliance and ensuring the quality of pharmaceutical products. While specific physical and chemical properties such as melting point, solubility, and stability may vary, they are essential for evaluating the compound's behavior in pharmaceutical applications.
- Rizatriptan IMpurity B
- DideMethyl Rizatriptan Hydrochloride
- 5-(1H-1,2,4-Triazol-1-ylMethyl)-1H-indole-3-ethanaMine Hydrochloride
- 5-(1H-1,2,4-Triazol-1-ylmethyl)-1H-indole-3-ethanamine hydrochloride (1:1)
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
Didemethyl rizatriptan hydrochloride
CAS:<p>Didemethyl rizatriptan hydrochloride is a potent anticancer agent that belongs to the indirubin analog family. It acts as a selective inhibitor of various kinases, including cyclin-dependent kinase (CDK), glycogen synthase kinase-3β (GSK-3β), and casein kinase 1 (CK1). This drug has been shown to induce apoptosis in various human cancer cell lines, including breast, prostate, and colon cancers. Didemethyl rizatriptan hydrochloride has also demonstrated significant tumor growth inhibition in animal models of cancer. Moreover, this drug can be detected in urine samples of Chinese patients with cancer who have received treatment with this inhibitor. Overall, didemethyl rizatriptan hydrochloride shows great promise as an effective protein kinase inhibitor for the treatment of cancer.</p>Formula:C13H16ClN5Purity:Min. 95%Molecular weight:277.75 g/mol
